Dr Jon Martin Winjum, MD | |
1420 John Adams St, Oregon City, OR 97045-1609 | |
(503) 656-1484 | |
(503) 650-1976 |
Full Name | Dr Jon Martin Winjum |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 31 Years |
Location | 1420 John Adams St, Oregon City, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730156639 | NPI | - | NPPES |
082987 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD20031 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Home Health | Portland, OR | Home health agency |
Providence Hospice | Portland, OR | Hospice |
Providence Willamette Falls Medical Center | Oregon city, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oregon City Family Practice Clinic,p.c. | 7719972546 | 5 |
News Archive
Roche announced today that its new lab-coagulation solution, the cobas t 411 analyzer, is now available for countries accepting the CE Mark.
Peanut allergy affects at least 4.5 million adults in the U.S., many of whom report developing their first allergy symptoms during adulthood, reports a new Northwestern Medicine study.
An intervention for pregnant women that included a computerized, interactive decision-support guide regarding prenatal genetic testing, and no cost for testing, resulted in less prenatal test use and more informed choices, according to a study in the September 24 issue of JAMA.
Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.
› Verified 6 days ago
Entity Name | Oregon City Family Practice Clinic,p.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043434053 PECOS PAC ID: 7719972546 Enrollment ID: O20040420000038 |
News Archive
Roche announced today that its new lab-coagulation solution, the cobas t 411 analyzer, is now available for countries accepting the CE Mark.
Peanut allergy affects at least 4.5 million adults in the U.S., many of whom report developing their first allergy symptoms during adulthood, reports a new Northwestern Medicine study.
An intervention for pregnant women that included a computerized, interactive decision-support guide regarding prenatal genetic testing, and no cost for testing, resulted in less prenatal test use and more informed choices, according to a study in the September 24 issue of JAMA.
Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jon Martin Winjum, MD 1420 John Adams St, Oregon City, OR 97045-1609 Ph: (503) 656-1484 | Dr Jon Martin Winjum, MD 1420 John Adams St, Oregon City, OR 97045-1609 Ph: (503) 656-1484 |
News Archive
Roche announced today that its new lab-coagulation solution, the cobas t 411 analyzer, is now available for countries accepting the CE Mark.
Peanut allergy affects at least 4.5 million adults in the U.S., many of whom report developing their first allergy symptoms during adulthood, reports a new Northwestern Medicine study.
An intervention for pregnant women that included a computerized, interactive decision-support guide regarding prenatal genetic testing, and no cost for testing, resulted in less prenatal test use and more informed choices, according to a study in the September 24 issue of JAMA.
Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.
› Verified 6 days ago
Veronica Mary Rayburn, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 Beavercreek Rd, Oregon City, OR 97045 Phone: 503-655-8471 Fax: 503-655-8595 | |
Anna Marian Tubman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1508 Division St, Suite 25, Plaza 2, Oregon City, OR 97045 Phone: 503-659-4988 Fax: 503-353-1234 | |
Julie Jolene Hurlocker, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1425 Beavercreek Rd, Oregon City, OR 97045 Phone: 206-550-7904 | |
Jennifer Backman, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 Beavercreek Rd, Oregon City, OR 97045 Phone: 503-655-8471 Fax: 503-655-8595 | |
Dr. William Charles Barth, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1230 Division St, Oregon City, OR 97045 Phone: 503-655-5327 Fax: 503-722-4499 | |
Dr. Alisha B Saultz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1508 Division St, Plaza 2, Suite 25, Oregon City, OR 97045 Phone: 503-659-4988 Fax: 503-353-1234 | |
Maria Nelida Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 702 John Adams, Oregon City, OR 97045 Phone: 503-657-3034 Fax: 503-657-1785 |